Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1607
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV